Davis Rea LTD. Trims Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• Davis Rea LTD. reduced its stake in UnitedHealth Group by 14.3% in Q2, owning 20,188 shares, valued at approximately $6.3 million.
• Institutional investments included new positions and increases in holdings, with 87.86% of the stock now held by these investors.
• UnitedHealth reported Q2 earnings of $4.08 per share, missing estimates, while also announcing a quarterly dividend of $2.21 per share.

Davis Rea LTD. trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.3% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 20,188 shares of the healthcare conglomerate's stock after selling 3,360 shares during the period. UnitedHealth Group accounts for approximately 1.6% of Davis Rea LTD.'s portfolio, making the stock its 22nd largest position. Davis Rea LTD.'s holdings in UnitedHealth Group were worth $6,298,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Nuveen LLC acquired a new position in shares of UnitedHealth Group during the first quarter worth about $3,846,764,000. Vanguard Group Inc. raised its holdings in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP raised its holdings in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. National Bank of Canada FI raised its holdings in UnitedHealth Group by 137.8% during the first quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate's stock worth $859,518,000 after purchasing an additional 950,928 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock worth $3,702,736,000 after purchasing an additional 847,054 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Cantor Fitzgerald reissued an "overweight" rating and set a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. JPMorgan Chase & Co. upped their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an "overweight" rating in a research report on Thursday. KeyCorp upped their target price on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an "overweight" rating in a research report on Wednesday. Zacks Research upgraded shares of UnitedHealth Group from a "strong sell" rating to a "hold" rating in a research report on Monday, October 6th. Finally, Sanford C. Bernstein upped their target price on shares of UnitedHealth Group from $379.00 to $433.00 and gave the stock an "outperform" rating in a research report on Wednesday. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $383.09.

UnitedHealth Group Stock Down 3.6%

UNH stock opened at $354.30 on Friday. The company's 50 day simple moving average is $318.21 and its 200-day simple moving average is $350.41. The firm has a market capitalization of $320.88 billion, a PE ratio of 15.35, a P/E/G ratio of 2.38 and a beta of 0.47. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the prior year, the company earned $6.80 earnings per share. The firm's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.